Aino Health AB (publ): Aino Health interim report January-March 2021
May 11, 2021
This document in English is a translation of the original in Swedish. In case of any discrepancy, the Swedish original will prevail.
Continued focus on Sweden to meet increased demand, SaaS subscriptions on a steady level
January – March 2021
• Net sales were KSEK 5,770 (6,085) *
• Profit/loss after financial items was KSEK -3,570 (-3,569)
• The operating result was KSEK -3,355 (-4,987)
• Earnings per share were SEK -0.1 (-0.2)
* The decrease in net sales is attributable to changes in exchange rates.
At the end of Q1 2021, the company had about MSEK 2.1 in accounts receivable from result-based contracts, accrued during Q42018–Q42020, of which SEK 2 million have been taken up as revenue during Q4 2019 and Q4 2020.
During the first quarter of the year, we have seen that the sales situation has stabilised and we can see that our sales pipeline is growing again.
We have gained new clients – including DHL Supply Chain Sweden AB, which has initiated a pilot project that is currently being implemented. We are very pleased to be working with one of the largest employers in the world and look forward to a long collaboration after the pilot phase. In Finland, Wihuri Oy has chosen to extend their HealthManager licenses to the operations throughout Finland, which has added another 700 SaaS subscribers.
We have continued to invest heavily in marketing and sales, especially in Sweden. This has resulted in higher costs but has also had results in the form of increased activity levels, the outcome of which will be seen in the coming quarters.
As of the last of March, we have around 50,000 subscribers.
Thanks to the improved sales situation in Sweden and the high activity level we have, I look forward to a continued strong 2021 that will bring us new clients, better visibility for Aino and an even better SaaS solution that will continue to support our clients in keeping their employees healthy and engaged.
CEO and President Aino Health AB
The information contained herein is such as shall be made public by Aino Health AB (publ), in accordance with the EU Market Abuse Regulation. This information was made public, through the agency of Jyrki Eklund, CEO and President of Aino Health AB, at 08.30 AM CET on May 11, 2021.
For more information:
Jyrki Eklund, CEO Aino Health, Phone: +358 40 042 4221
Erik Penser Bank
+46 8 463 83 00
About Aino Health (publ)
Aino Health is the leading supplier of Software as a Service solutions in Corporate Health Management. The company’s complete system of SaaS platforms and services reduces sick leave, lowers related costs, and improves business results through increased productivity and employee engagement by making health, wellbeing, and safety an integrated part of everyday work. For more information visit ainohealth.com. Aino Health AB (publ) is listed on Nasdaq First North Growth Market (Ticker: AINO).
For more information: https://investors.ainohealth.com/en.
Upcoming Life Sciences Events
- September 2021
- Navarro: BioSpain 2021
- October 2021
- HealthTech Innovation Days
- 8th Annual HealthTech Investment Forum